Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (179)	5/2/2002 11:57:57 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 598

>> Still a heavy seller out there. << There are fund managers that are bailing from biotech, period. Getting out. This has happened in the past. The FMs have always, subsequently, looked silly. The fund, perhaps minus manager(s), scrambles back in later and at a higher price. Why is it, again, that most fund managers don't beat market averages?

To: mopgcw who wrote (179)	5/24/2002 3:26:08 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 598

>> Still a heavy seller out there << To me, bewildering. If I could find nine more companies like Tularik for an equally weighted basket of 10, I'd just go on vacation for three years. A potential for mind-boggling appreciation. As for all development-stage biotechs, also the potential for $0/share.